The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
((1S,2S,4R)-2-hydroxy-4-(8-phenyl-9H-purin-6-yloxy)cyclopentyl)methyl sulfamate ID: ALA3985244
PubChem CID: 59671216
Max Phase: Preclinical
Molecular Formula: C17H19N5O5S
Molecular Weight: 405.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: NS(=O)(=O)OC[C@@H]1C[C@@H](Oc2ncnc3[nH]c(-c4ccccc4)nc23)C[C@@H]1O
Standard InChI: InChI=1S/C17H19N5O5S/c18-28(24,25)26-8-11-6-12(7-13(11)23)27-17-14-16(19-9-20-17)22-15(21-14)10-4-2-1-3-5-10/h1-5,9,11-13,23H,6-8H2,(H2,18,24,25)(H,19,20,21,22)/t11-,12+,13-/m0/s1
Standard InChI Key: NEMRBWQVVJBHKJ-XQQFMLRXSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
27.0994 -21.7381 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.5121 -22.4480 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
27.9205 -21.7356 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.9265 -23.1827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7437 -23.1827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9981 -22.4060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3351 -21.9238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6764 -22.4060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4453 -23.8432 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.8991 -22.1538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2920 -22.7009 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.9077 -22.9958 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.7756 -22.1545 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.3821 -22.7022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2088 -23.4994 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.8145 -24.0468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5931 -23.7955 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.1553 -22.4478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7632 -22.9880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4648 -22.5768 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.2906 -21.7824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4813 -21.7028 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.8302 -21.1719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6315 -21.3381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1740 -20.7280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9166 -19.9515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1115 -19.7886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5724 -20.4000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 4 1 0
4 9 1 6
8 10 1 6
10 11 1 0
11 2 1 0
2 12 1 0
6 13 1 1
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 19 1 0
18 14 1 0
18 19 2 0
19 20 1 0
20 21 1 0
21 22 2 0
22 18 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
21 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 405.44Molecular Weight (Monoisotopic): 405.1107AlogP: 0.76#Rotatable Bonds: 6Polar Surface Area: 153.31Molecular Species: NEUTRALHBA: 8HBD: 3#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.52CX Basic pKa: 2.63CX LogP: 0.51CX LogD: 0.48Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.54Np Likeness Score: -0.13
References 1. (2008) Heteroaryl compounds useful as inhibitors of E1 activating enzymes, 2. (2013) Inhibitors of nedd8-activating enzyme,